Anixa Biosciences gets notice of allowance for patent application for its ovarian cancer vaccine technology from USPTO: San Jose, California Thursday, March 27, 2025, 17:00 Hrs [I ...
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine. Anixa Biosciences, Inc. March 24, 2025.
Anixa Biosciences, Inc. (NASDAQ:ANIX) entered into a letter of intent with VERDI Solutions GmbH to develop personalized and ...
On Monday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a key patent application ...
Monitoring Anti-Müllerian Hormone (AMH) levels can provide essential insights into ovarian reserve and fertility, aiding in informed decisions about family planning and potential fertility ...
8mon
Motherly on MSNShould you get an anti-mullerian hormone test?“Had I known earlier, I think I would have made different decisions that would have benefited me very differently now.” Kelly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results